To explore the relationship between vascular health and cognitive function, particularly in the context of dementia risk.
Key Findings:
Hypertension is linked to increased dementia risk; antihypertensive treatment can reduce this risk.
Lower LDL cholesterol levels are associated with reduced dementia risk, with additional benefits from statins.
GLP-1 receptor agonists and SGLT2 inhibitors are associated with reduced incidence of Alzheimer's disease dementia in type 2 diabetes patients.
Targeting vascular risk factors may provide a cost-effective strategy to reduce dementia risk at a population level.
Interpretation:
Optimizing vascular health through management of blood pressure, cholesterol, and glucose levels may significantly enhance brain health and reduce dementia risk.
Limitations:
Individual trial data on antihypertensives and dementia are limited.
The mechanisms behind some drug effects on dementia risk remain unclear.
Conclusion:
Targeting vascular health presents a promising approach to improve cognitive function and reduce dementia risk, particularly in low and middle-income countries.